Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients

✍ Scribed by Carlo Buonerba; Piera Federico; Carmine D’Aniello; Pasquale Rescigno; Carla Cavaliere; Livio Puglia; Matteo Ferro; Vincenzo Altieri; Sisto Perdonà; Sabino De Placido; Giuseppe Di Lorenzo

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 86 KB
• Volume: 67
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-011-1626-8